Healthcare -
Biotechnology - NASDAQ - US
$ 108.9718
0.112 %
$ 5.28 B
Market Cap
-16.56
P/E
AXSM - LONG-TERM DEBT
Long-term Debt AXSM - Axsome Therapeutics, Inc.
185 M
LAST VALUE
94.18%
2 YEAR CAGR
119.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR